2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
about
sameAs
Third-line systemic treatment for non-small cell lung cancerDNA damage triggers Golgi dispersal via DNA-PK and GOLPH3A review of clinical practice guidelines for lung cancerGefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic reviewPemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review)The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFRSystemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateCisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data.A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial.Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.Comparing single-agent with doublet chemotherapy in first-line treatment of advanced non-small cell lung cancer with performance status 2: a meta-analysis.Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer.American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer.Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer.Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules.Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy.Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRASPARAMOUNT: Descriptive subgroup analyses of final overall survival for the phase III study of maintenance pemetrexed versus placebo following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerClinical significance of BIM deletion polymorphism in non-small-cell lung cancer with epidermal growth factor receptor mutation.Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC)Crizotinib in the treatment of non-small-cell lung cancer.The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective studySimultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapyCost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III studyOverall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapyPrognostic role of ERCC1 in advanced non-small-cell lung cancer: a systematic review and meta-analysis.PVM/MA-shelled selol nanocapsules promote cell cycle arrest in A549 lung adenocarcinoma cells.2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer.
P2860
Q24194090-6C61F5A1-4111-4DDC-82F1-C381EAF5A7F0Q24324801-96FDE1A2-2F09-4503-A24C-8B0F71726A89Q26999236-3A2F4D23-A394-457C-9FB5-35142AAF02B4Q27023100-C9BB602F-A7F1-4CCD-8ECE-D5771838D5F8Q28081243-56E9D272-EB10-4131-BD39-D5CD633E3DF5Q28082896-525C5420-6F56-46F0-ACD3-E700389B54BBQ28086993-D20A27FE-7E46-4D71-AE02-C8FBC8FE19E1Q30356434-5BB03908-EF6B-4FDD-A187-332F10B3F1F7Q30784508-4004F716-B469-41BC-95A7-5FD60DF45127Q33166212-D1A7BF14-0793-475F-ABD9-5B9FEA79AD70Q33406653-51E8BD69-45DB-45F1-969B-F097765E8B79Q33421926-A0026BC7-5CAA-40ED-B07F-84F32C1F68DDQ33425130-FBAB0C52-E43D-405B-B494-5ED17337E7ACQ33430874-63116187-C99B-4D15-B7BD-2CC9B9C29AD3Q33432327-ACC1C188-03D1-4D81-8286-398A008D8565Q33432898-41D8A84E-628C-400C-87D2-63961EBADD11Q33586120-0109A997-DA75-46B2-9EA2-1134E6BD0DA6Q33639335-9D204E29-3AEB-4DF3-82F5-1EC2521F5BFEQ33727616-66470578-D97A-438C-9CA9-C1E3416E8ADAQ33754141-8B99F1EB-E16E-4BF8-BC09-72759AAEEB21Q33847273-FD5EBB1B-0CAD-422E-B79D-31A5EB90A0F8Q34023414-44DBD67E-538F-4CDD-9D49-06C276ABD8DCQ34041708-55AF18BE-7D76-460C-9400-CAFF9CFA1C7DQ34041761-5D31747A-E8D1-4A45-87D8-CAF5960A8131Q34271752-A67D2BBA-74E7-4523-9B2C-FF35135B3848Q34275584-A36B051A-3A16-4777-8E28-F087F6FA135EQ34331575-3A1AA75A-B03E-4765-931A-BEF95538DA9DQ34362184-68ECF2F6-8DB3-4C07-B68E-60F23EBA3A88Q34479081-FD9AE38A-3268-4FDF-82B0-6EB60625EDD6Q34486090-BD13B494-388A-42A6-A791-09E71FAD9746Q34589991-B3237718-2BAF-4E45-8037-2E7F2FC2F6C9Q34781002-3F214BA7-1998-4EDE-AEB3-3BD0D3619770Q34996046-C770407B-0331-4919-8973-B5867D7B9CE5Q35015692-B58245B8-6239-42DD-BEE6-B92877197320Q35397008-55469F0E-9D89-4C16-8DD3-F8137A6EC507Q35510634-4B16C57A-9207-4170-88AE-1A215AE5E281Q35576278-41D2DF0A-8E03-476B-BB15-460434E94C57Q35695906-BC7A1D7D-1607-4079-B069-D069F6B84BFBQ35872968-CE2D71C2-D0A3-4CCC-BCF2-41EA71D26C79Q36115981-6E72FA98-96F2-4E9B-8A6C-91D60724E1F2
P2860
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@ast
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@en
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@en-gb
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@nl
type
label
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@ast
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@en
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@en-gb
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@nl
prefLabel
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@ast
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@en
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@en-gb
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@nl
P2093
P2860
P50
P3181
P356
P1476
2011 Focused Update of 2009 Am ...... IV Non-Small-Cell Lung Cancer
@en
P2093
C. G. Azzoli
Christopher G Azzoli
D. G. Pfister
D. H. Johnson
Daniel Milton
David G Pfister
David H Johnson
David Trent
P2860
P304
P3181
P356
10.1200/JCO.2010.34.2774
P407
P577
2011-09-06T00:00:00Z
2011-10-01T00:00:00Z